• David Charles at Future Unpacked, by Food & Drink Business + PKN LIVE 2017
    David Charles at Future Unpacked, by Food & Drink Business + PKN LIVE 2017
  • Peter Taitoko at Future Unpacked, by Food & Drink Business + PKN LIVE 2017
    Peter Taitoko at Future Unpacked, by Food & Drink Business + PKN LIVE 2017
Close×

On the eve of the official opening of Birch & Waite's new food manufacturing facility in Revesby, Sydney, we learned how the factory has been designed for the future.

GM of Birch & Waite, David Charles and MD of RMR Process, Peter Taitoko presented on the design thinking behind the mid-tier food manufacturer's new facility, where some of the company's more innovative products will be processed and packed.

David Charles gave a background to the company and its drive for innovation and quality, and described some of the new technology in place at the plant, including the latest thermoprocessing equipment and specialised sachet filling and packing line.

Peter Taitoko explained the process that his team followed with Birch & Waite to save them millions of dollars in plant design and construction costs, by establishing what the company needs now and building that, but designing and putting in place the necessary infrastructure to accommodate future automation and expansion.

Our editorial team will be attending the opening this Friday, and will bring you the full story in next week's enews.

Food & Drink Business

New CEO for Bulla

Family-owned manufacturer, Bulla Dairy Foods, has appointed Peter Hall as CEO. Hall joins in September, returning to Australia after more than 25 years running food and beverage businesses across North America, Europe, Latin America and the Caribbean.

Treasury Wine Estates has reported a statutory net loss of $1,078.7 million for FY26, with $1.31 billion in post-tax material items from its US write-downs drowning out an operating result that landed ahead of guidance.

Seedlab Australia says FMCG brands need to be more thoughtful about whether protein genuinely adds value, or whether it risks becoming the next overused health claim.